Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2014
11/11/2014US8883220 Compositions of jasmonate compounds
11/11/2014US8883217 Modified release formulations containing drug-ion exchange resin complexes
11/11/2014US8883214 Implantable delivery vehicle for ocular delivery of muscarinic antagonists
11/11/2014US8883213 Ion exchange resin treated to control swelling
11/11/2014US8883209 Pharmaceutical solid dispersions
11/11/2014US8883204 Tamper resistant co-extruded dosage form containing an active agent and an adverse agent and process of making same
11/11/2014US8883203 Solid oral dosage form containing an enhancer
11/11/2014US8883202 Lipid compositions
11/11/2014US8883201 Solid oral dosage form containing an enhancer
11/11/2014US8883200 Delivery of nucleic acid-like compounds
11/11/2014US8883197 Transdermal, therapeutic system with activatable oversaturation and controlled permeation promotion
11/11/2014US8883196 Transdermal hormone delivery system: compositions and methods
11/11/2014US8883191 Method for producing individually dosed active substance-containing and, in particular, aromatics-containing film-shaped administration forms rapidly disintegrating upon contact with liquid
11/11/2014US8883185 Hydrogel implants with varying degrees of crosslinking
11/11/2014US8883177 Pharmaceutical compositions for parenteral administration
11/11/2014US8883176 Smooth, high solids tablet coating composition
11/11/2014US8883162 Multivalent antibody complexes targeting IGF-1R show potent toxicity against solid tumors
11/11/2014US8883160 Dock-and-lock (DNL) complexes for therapeutic and diagnostic use
11/11/2014US8883148 Prevention of joint destruction
11/11/2014US8883133 Pharmaceutical compositions comprising polymeric binders with non-hydrolysable their use in treating celiac disease
11/06/2014US20140330244 Implantable Device for Manipulating Immune Cells
11/06/2014US20140330198 Microneedle device having a peptide therapeutic agent and an amino acid, methods of making and using the same
11/06/2014US20140330041 Thiol-selective water-soluble polymer derivatives
11/06/2014US20140330021 Benzoic Acid, Benzoic Acid Derivatives and Heteroaryl Carboxylic Acid Conjugates of Hydromorphone, Prodrugs, Methods of Making and Use Thereof
11/06/2014US20140330005 Polysaccharide therapeutic conjugates
11/06/2014US20140329994 Branched polymers
11/06/2014US20140329990 Hydroxyapatite-Targeting Multiarm Polymers and Conjugates Made Therefrom
11/06/2014US20140329915 Hydrogel adapted for treatment of acute dermal wounds
11/06/2014US20140329914 Amphiphilic Peptides for Thoracic Air Leakage Occlusion
11/06/2014US20140329913 Nanoparticles with enhanced mucosal penetration or decreased inflammation
11/06/2014US20140329906 Thermogelling anaesthetic compositions
11/06/2014US20140329904 Increasing the bioavailability of hydroxycinnamic acids
11/06/2014US20140329896 Compositions and methods of treatment with proanthocyanidin polymer antidiarrheal compositions
11/06/2014US20140329895 Oligomer-cannabinoid conjugates
11/06/2014US20140329886 Single-stranded nucleic acid molecule having amino acid backbone
11/06/2014US20140329885 Lipids, lipid complexes and use thereof
11/06/2014US20140329859 Ionic silicone hydrogels comprising pharmaceutical and/or neuticeutical components and having improved hydrolytic stability
11/06/2014US20140329847 Method of treating pain utilizing controlled release oxymorphone pharmaceutical compositions and instruction on dosing for renal impairment
11/06/2014US20140329828 Oligomer-Protein Tyrosine Kinase Inhibitor Conjugates
11/06/2014US20140329793 Pharmaceutical compositions and uses thereof
11/06/2014US20140329788 Testosterone gel and method of use
11/06/2014US20140329775 Self delivering bio-labile phosphate protected pro-oligos for oligonucleotide based therapeutics and mediating rna interference
11/06/2014US20140329774 Injectable composition containing phosphatidylcholine devoid of sodium deoxycholate and preparing method thereof
11/06/2014US20140329764 Novel methods of use of hsp70 for increased performance or treatment of hsp70 related disorders
11/06/2014US20140329759 Polyethylene glycol-modified integrin blocker hm-3 and use thereof
11/06/2014US20140329750 Growth Hormones with Prolonged In-Vivo Efficacy
11/06/2014US20140329749 Robust controlled-release peptide formulations
11/06/2014US20140329744 Stable non-aqueous liquid pharmaceutical compositions comprising an insulin
11/06/2014US20140329737 Development of Novel Macromolecule Transduction Domain with Improved Cell Permeability and Method for Using Same
11/06/2014US20140329290 Novel branched polyethylene glycol and use thereof
11/06/2014US20140328943 Insulin compositions and method of making a composition
11/06/2014US20140328938 Pharmaceutical Compositions Comprising Renewably-Based Biodegradable 1,3-Propanediol
11/06/2014US20140328936 Novel pharmaceutical statin composition
11/06/2014US20140328933 Novel formulations and methods
11/06/2014US20140328928 Stable Aqueous Suspension
11/06/2014US20140328927 Anti-cancer nanoparticle compositions and methods of use
11/06/2014US20140328926 Modified hyaluronic acid polymer compositions and related methods
11/06/2014US20140328923 Dosing combinations for reducing undesired humoral immune responses
11/06/2014US20140328921 Tolerogenic synthetic nanocarriers to reduce or prevent anaphylaxis in response to a non-allergenic antigen
11/06/2014US20140328919 Polymer-agent conjugates, particles, compositions, and related methods of use
11/06/2014US20140328918 Methods of treating a subject and related particles, polymers and compositions
11/06/2014US20140328915 Dosage form for insertion into the mouth
11/06/2014US20140328907 Entrapment of bioactives in sol-gel alumina materials
11/06/2014US20140328905 Methods and compositions for x-ray induced release from ph sensitive liposomes
11/06/2014US20140328897 Charge triggering of self-organized nanoparticles
11/06/2014US20140328895 Film-forming composition for a ph-dependant sustained release of the active agent
11/06/2014US20140328884 Controlled release vehicles having desired void volume architectures
11/06/2014US20140328878 Malleable protein matrix and uses thereof
11/06/2014US20140328866 Peptide-Mediated Non-Covalent Delivery of Active Agents Across the Blood-Brain Barrier
11/06/2014US20140328865 Immune Modulation Via C-Type Lectin
11/06/2014US20140328857 Novel B7-H3L Cell Surface Antigen and Antibodies That Bind Thereto
11/06/2014US20140328854 Tolerogenic synthetic nanocarriers and therapeutic macromolecules for reduced or enhanced pharmacodynamic effects
11/06/2014US20140328849 Anti-crth2 antibodies and methods of use
11/06/2014US20140328837 Affinity Peptides Toward Infliximab
11/06/2014US20140328835 Methods for treating retinopathy with extended therapeutic effect
11/06/2014US20140328830 Anti-integrin beta-1 antibody compositions and methods of use thereof
11/06/2014US20140328791 Conjugates of an IL-2 Moiety and a Polymer
11/06/2014US20140328776 Film forming personal care compositions and methods
11/06/2014US20140328770 Topical tetracycline compositions
11/06/2014US20140328763 Bioactive amphiphilic polymer stabilized nanoparticles with enhanced stability and activity
11/06/2014US20140328759 Limit size lipid nanoparticles and related methods
11/06/2014US20140328758 Use of fsh receptor ligands for diagnosis and therapy of cancer
11/06/2014US20140328757 Compositions comprising ascorbic acid and an imaging agent and related methods
11/06/2014US20140328752 Immunoconjugates with an Intracellularly-Cleavable Linkage
11/06/2014US20140328751 Antibodies that bind ov064 and methods of use therefor
11/06/2014US20140326759 Medicinal aerosols and methods of delivery thereof
11/04/2014US8877928 Pegylated cyclopamine analogue, preparation method and uses thereof
11/04/2014US8877917 Glycoconjugates of RNA interference agents
11/04/2014US8877902 Formulations and methods for weight loss and body contouring
11/04/2014US8877901 Camptothecin-binding moiety conjugates
11/04/2014US8877813 Antiinflammatory and analgesic preparation for external use
11/04/2014US8877792 Compositions for increasing solubility of azole drug compounds that are poorly soluble in water
11/04/2014US8877790 Allantoin-containing skin cream
11/04/2014US8877789 Allantoin-containing skin cream
11/04/2014US8877788 Allantoin-containing skin cream
11/04/2014US8877746 Compositions for delivery of insoluble agents
11/04/2014US8877729 Amino acid lipids and uses thereof
11/04/2014US8877726 Method and medicament for inhibiting the expression of a given gene
11/04/2014US8877716 Peptide derivatives, preparation and uses thereof
11/04/2014US8877709 Reversible pegylated drugs
1 ... 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 ... 1712